Skip to main content

Table 3 Change in parameters following iron therapy

From: Anemia, diet and therapeutic iron among children living with HIV: a prospective cohort study

Parameters

Timing (from enrolment)

Received iron supplements

Iron supplement not received

p

Hemoglobin (g/dl)

Baseline

10.4

12.0

0.003*

3 months

10.9

12.0

0.04*

1 year

11.3

11.9

0.2

Weight-for-age Z score

Baseline

−2.2

−1.9

0.08

1 year

−1.9

−1.8

0.2

Height-for-age Z score

Baseline

−1.6

−1.5

0.2

1 year

−1.3

−1.7

0.05

CD4%

Baseline

21.0

20.5

0.6

1 year

26.5

26.0

0.7

Prevalence of advanced WHO clinical stage (Stage 3, 4) (%)

Baseline

25.7

16.7

0.04*

1 year

10.9

12.5

1.0

Fe deficiency prevalence (STfR/lf) >1.5) (%)

Baseline

68.1

62.7

0.04*

1 year

49.2

58.0

1.0

Chronic inflammation (CRP > 1) (%)

Baseline

62.9

52.4

0.05

1 year

57.9

40.0

0.06

  1. Children (n = 194) were followed for one year, and the change in parameters are compared between those who received and did not short-course iron supplementation
  2. WHO World Health Organization, sTfR/lf soluble transferrin receptor-log ferritin index, CRP C-reactive protein
  3. * refers to statistical significance at a level or p > 0.05